Matches in Nanopublications for { ?s ?p "Mirabegron is a beta-3 adrenergic receptor agonist for the management of overactive bladder. It is an alternative to antimuscarinic drugs for this indication. FDA approved on June 28, 2012."@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.